Trelegy Ellipta filing accepted by EMA for asthma
As it stands there is no single inhaled triple therapy available for the treatment of asthma in Europe.
Read More
Author: Anna Smith
Bicycle, Roche collab for immuno-oncology therapies
Under the terms of the agreement, the companies will collaborate on the discovery and pre-clinical development of novel Bicycle-based immunotherapies against multiple targets.
Read More
European partnerships to ‘accelerate’ cancer research
The project will look at rare and hard-to-treat cancers, helping to find better ways to treat them.
Read More
Biogen, Sangamo team up on neurological diseases
The companies have detailed plans to leverage Sangamo’s proprietary zinc finger protein (ZFP) technology.
Read More
Study finds industry ‘paying price’ for ill-prepared negotiators
The pharma industry is launching into deals “ill-prepared”, Scotwork claims.
Read More- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
